Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 16 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
151 28.9 months Metastatic breast cancer 5 Biologic therapy
Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 1/2014
Treatment Details: Patients: This phase 3 study involved female HER2-positive metastatic breast cancer patients who were divided into two separate treatment groups. Group A consisted of 181 patients and grou
 
152 28.9 months Hormone-refractory prostate cancer 3 Biologic therapy
Chemotherapy
National Cancer Institute, National Institutes of Health United States 7/2004
Treatment Details: Patients: This Phase II trial involved a total of 75 patients with hormone refractory (androgen-independent) prostate cancer. Patients were divided into two groups: Group 1 comprised of 25
 
153 28.8 months Hepatocellular carcinoma 4 Alternative
Biologic therapy
Chemotherapy
Guangdong Academy of Medical Sciences China 12/2013
Treatment Details: Patients: This study involved 30 hepatocellular carcinoma patients with an average age of 58 years; 22 patients were male. Treatment: Patients received chemotherapy with oxaliplatin and
 
154 28.8 months Ovarian cancer 5 Chemotherapy
St. James's University Hospital United Kingdom 12/2011
Treatment Details: Patients: This phase 3 study involved women with ovarian cancer who were divided into 2 separate treatment groups. Group A consisted of 764 patients with a median age of 57 years (range of
 
155 28.6 months Breast 4 Biologic therapy
The West Clinic United States 2/2014
Treatment Details: Patients: This phase 2 study involved 41 postmenopausal women with hormone receptor-positive, HER2-negative breast cancer. The median patient age was 64.5 years. Treatment: Patients we
 
156 28.5 months Advanced colorectal cancer 4 Biologic therapy
Chemotherapy
National Hospital Organization Shikoku Cancer Center Japan 9/2013
Treatment Details: Patients: This study involved 68 advanced/recurrent colorectal cancer patients who had not received prior chemotherapy. The median patient age was 63 years and 38 were male. Treatment:
 
157 28.5 months HER2-positive metastatic breast cancer 5 Biologic therapy
Chemotherapy
Mayo Clinic United States 4/2012
Treatment Details: Patients: This phase 2 study involved 46 HER+ metastatic breast cancer patients (all female) with a median age of 60 years. Treatment: Patients were treated with the chemotherapy agents
 
158 28.4 months GBM 5 Chemotherapy
Radiation
Seoul National University Hospital Korea 11/2010
Treatment Details: Patients: In this study, glioblastoma patients were separated into two different treatment groups. Group A consisted of 42 patients with a median age of 51.1 years, 35.7% of whom were male
 
159 28.2 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Hormone
National Cancer Institute United States 4/2010
Treatment Details: Patients: This study involved 60 male patients with metastatic castration-resistant prostate cancer. The median age of the group was 66 years with a range of 44-79. Treatment: Patients
 
160 28.2 months Ovarian cancer 5 Biologic therapy
Chemotherapy
The Royal Marsden Hospital United Kingdom 9/2012
Treatment Details: Patients: This phase II study involved 74 women with previously treated ovarian cancer. The median age was 58.1 years. Treatment: Patients were treated with a combination of the chem
 
Page 16 of 187  | Previous Page  | Next Page